Development and validation of patient-community pharmacist encounter toolkit regarding substance misuse: Delphi procedure
Fatani S, Bakke D, Halpape K, D’Eon M, El-Aneed A., J Am Pharm Assoc. 2022
PÔLE
Prairies
Publications
Clinicians’ perspectives and perceived barriers to caring for patients with alcohol use disorder and cirrhosis
Johnson E, Ghosh SM, Daniels VJ, Wild TC, Tandon P, Hyde A., Addict Sci Clin Pract. 2022
Prescription drug misuse among adults in Canada: a scoping review
Abayateye, F., Fornssler, B., Feng, C., D’Arcy, C., Alphonsus, K., Journal of Substance Use. 2022
Impact of an addiction medicine consult team intervention in a Canadian inner city hospital on acute care utilization: a pragmatic quasi-experimental study
Salvalaggio G, Dong KA, Hyshka E, McCabe C, Nixon L, Rosychuk RJ, Dmitrienko K, Krajnak J, Mrklas K, Wild TC., Subst Abuse Treat Prev Policy. 2022
Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review
Bahji A, Breward N, Duff W, Absher N, Patten SB, Alcorn J, Mousseau DD., J Cannabis Res. 2022
People who make frequent emergency department visits based on persistence of frequent use in Ontario and Alberta: a retrospective cohort study
Moe J, Wang EY, McGregor MJ, Schull MJ, Dong K, Holroyd BR, Hohl CM, Grafstein E, O’Sullivan F, Trimble J, McGrail KM., CMAJ Open. 2022
Subgroups of people who make frequent emergency department visits in Ontario and Alberta: a retrospective cohort study
Moe J, Wang EY, McGregor MJ, Schull MJ, Dong K, Holroyd BR, Hohl CM, Grafstein E, O’Sullivan F, Trimble J, McGrail KM., CMAJ Open. 2022
Emergency department care for patients who use opioids during the COVID-19 pandemic
Weicker SA, Speed KA, Hyshka E, Mrochuk M, Kosteniuk B, Dong K., CJEM. 2022
Cannabis Use and Concern Among Clients Seeking Substance Misuse Treatment: Demographics, Comorbidities, and Service Utilization Patterns Pre-Legalization (2012–2018)
Williamson N, Hathaway J, Jahrig J, Vik S, Rittenbach K., Canadian Journal of Addiction, 2022
Impact of health system engagement on the health and well-being of people who use drugs: a realist review protocol
Salvalaggio, G., Ferguson, L., Brooks, H.L. et al., Syst Rev, 2022
The state of science on including inhalation within supervised consumption services: A scoping review of academic and grey literature
Gehring ND, Speed KA, Launier K, O’Brien D, Campbell S, Hyshka E., Int J Drug Policy. 2022
Self-Reported Cannabis Use and HIV Viral Control among Patients with HIV Engaged in Care: Results from a National Cohort Study
Bahji A, Li Y, Vickers-Smith R, Crystal S, Kerns RD, Gordon KS, Macmadu A, Skanderson M, So-Armah K, Sung ML, Bhondoekhan F, Marshall BDL, Edelman EJ., Int J Environ Res Public Health. 2022
A scoping review of opioid harm reduction interventions for equity-deserving populations
Milaney K, Haines-Saah R, Farkas B, Egunsola O, Mastikhina L, Brown S, Lorenzetti D, Hansen B, McBrien K, Rittenbach K, Hill L, O’Gorman C, Doig C, Cabaj J, Stokvis C, Clement F. , Lancet Reg Health Am. 2022
“I have such a hard time hitting myself, I thought it’d be easier”: perspectives of hospitalized patients on injecting drugs into vascular access devices
Brooks HL, Salvalaggio G, Pauly B, Dong K, Bubela T, Taylor M, Hyshka E., Harm Reduct J. 2022
Impacts of racism on First Nations patients’ emergency care: results of a thematic analysis of healthcare provider interviews in Alberta, Canada
Hassan AN, Bozinoff N, Jutras-Aswad D, Socias ME, Stewart SH, Lim R, Le Foll B; OPTIMA Research Group.,
Management of Post-Acute Alcohol Withdrawal: A Mixed-Studies Scoping Review
Bahji A, Crockford D, El-Guebaly N., J Stud Alcohol Drugs. 2022
Neurobiology and Symptomatology of Post-Acute Alcohol Withdrawal: A Mixed-Studies Systematic Review
Bahji A, Crockford D, El-Guebaly N., J Stud Alcohol Drugs. 2022
Response to “Operational and contextual barriers to accessing supervised consumption services in two Canadian cities”
Brooks HL, Speed K, Lopez E, O’Gorman C, Haines-Saah R, Hyshka E., Int J Drug Policy. 2022
Characterizing people with frequent emergency department visits and substance use: a retrospective cohort study of linked administrative data in Ontario, Alberta, and B.C., Canada
Moe J, Wang YE, Schull MJ, Dong K, McGregor MJ, Hohl CM, Holroyd BR, McGrail KM., BMC Emerg Med. 2022
Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders among Patients with Medical Cannabis Authorization: A Cohort Study
Zongo A, Lee C, Dyck JRB, El-Mourad J, Hyshka E, Hanlon JG, Eurich DT., Subst Use Misuse. 2022
Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study
Gehring ND, Speed KA, Wild TC, Pauly B, Salvalaggio G, Hyshka E., Int J Drug Policy. 2022
Retrospective Cohort Study Examining the Correlates of Reported Lifetime Stimulant Use in Persons Diagnosed With Infectious Syphilis in Alberta, Canada, 2018 to 2019
Raval M, Gratrix J, Plitt S, Niruban J, Smyczek P, Dong K, Singh AE., Sex Transm Dis. 2022
Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice
Hodgins DC, Budd M, Czukar G, Dubreucq S, Jackson LA, Rush B, Quilty LC, Adams D, Cameron Wild T., Can J Psychiatry. 2022
Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report
MacAusland-Berg J, Wiebe A, Marwah R, Halpape K., Can J Pain. 2022
Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review
Pijl, E.M., Alraja, A., Duff, E., Cooke, C., Dash, S., Nayak, N., Lamoureaux, J., Pouline, G., Knight, E., Fry, B., Subst Abuse Treat Prev Policy. 2022
Office-based Methadone Prescribing for Opioid Use Disorder: The Canadian Model
Kleinman RA, Brothers TD, Danilewitz M, Bahji A., J Addict Med. 2022
Public health approaches to substance use: a scoping review protocol
Kosteniuk B, Speed K, Candler E, Campbell S, Penney G, Moen K, Hyshka E. , JBI Evid Synth. 2022
Social service providers’ perspectives on caring for structurally vulnerable hospital patients who use drugs: a qualitative study
Gehring ND, Speed KA, Dong K, Pauly B, Salvalaggio G, Hyshka E. , BMC Health Serv Res. 2022
Challenges and opportunities for further research involving the cannabis-to-opioid use transition
Bahji A, Milloy MJ, Bach P, Sociás ME. Addiction. 2022
Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta-analysis
Bahji A, Bach P, Danilewitz M, Crockford D, El-Guebaly N, Devoe DJ, Saitz R., Addiction. 2022
Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis
Bahji A, Bach P, Danilewitz M, Crockford D, Devoe DJ, El-Guebaly N, Saitz R. J Addict Med. 2022
Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies
De Aquino JP, Bahji A, Gómez O, Sofuoglu M., Drug Alcohol Depend. 2022
Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence
Andrews CN, Rehak R, Woo M, Walker I, Ma C, Forbes N, Rittenbach K, Hathaway J, Wilsack L, Liu A, Nasser Y, Sharkey KA.
Letter to the Editor: Cannabis as a Solution to the Opioid Crisis: Is the Cart Before the Horse Again?
De Aquino JP, Bahji A, D’Souza DC., Cannabis Cannabinoid Res. 2022
Documenting cannabis use in primary care: a descriptive cross-sectional study using electronic medical record data in Alberta, Canada
Soos B, Garies S, Cornect-Benoit A, Montgomery L, Sharpe H, Rittenbach K, Manca D, Duerksen K, Forst B, Drummond N., BMC Res Notes., 2024
An Experiential Approach to Canine-Assisted Learning in Corrections for Prisoners Who Use Substances
Kosteniuk B, Dell CA, Cruz M, Chalmers D., Forensic Nurs. 2023
Buprenorphine/naloxone initiation and referral as a quality improvement intervention for patients who live with opioid use disorder: quantitative evaluation of provincial spread to 107 rural and urban Alberta emergency departments
Stone KD, Scott K, Holroyd BR, Lang E, Yee K, Taghizadeh N, Deol J, Dong K, Fanaeian J, Ghosh M, Low K, Ross M, Tanguay R, Faris P, Day N, McLane P., CJEM. 2023
Public support for safer supply programs: analysis of a cross-sectional survey of Canadians in two provinces
Morris H, Bwala H, Wesley J, Hyshka E., Can J Public Health. 2023
Using spatial video geonarratives to improve nursing care for people who use drugs and experience homelessness: A methodology for nurses
Jackson, J., Ewanyshyn, A., Perry, S., Ens, T., Ginn, C., Keanna, C., Armstrong, G., Ajayakumar, J., Curtis, J., & Curtis, A., Journal of Advanced Nursing, 2023
Operating an overdose prevention site within a temporary emergency shelter during the COVID-19 pandemic
Galarneau LR, Speed K, Taylor M, Hyshka E., Can J Public Health. 2023
Preclinical evidence for the use of the atypical antipsychotic, brexpiprazole, for opioid use disorder
Nickols JER, Dursun SM, Taylor AMW., Neuropharmacology. 2023
Unleashing compassionate care: canine-assisted intervention as a promising harm reduction approach to prisonization in Canada and its relevance to forensic psychiatry
Gibson M, Dell CA, Chalmers D, Rath G, Mela M. , Front Psychiatry., 2023
“They talk to me like a person”: Experiences of People in an Injectable Opioid Agonist Treatment Program: A Qualitative Interpretive Description
Jackson J, Colborne M, Gadimova F, Kennedy M.C., Journal of Addictions Nursing, 2023
Associations between adverse childhood experiences and substance use: A meta-analysis
Zhu J, Racine N, Devereux C, Hodgins DC, Madigan S., Child Abuse Negl. 2025
Case report: A community case study of the human-animal bond in animal-assisted therapy: the experiences of psychiatric prisoners with therapy dogs
Smith S, Dell CA, Claypool T, Chalmers D, Khalid A., Front Psychiatry., 2023
Implications of Cannabis Legalization on Substance-Related Benefits and Harms for People Who Use Opioids: A Canadian Perspective
Bahji A, Socias ME, Bach P, Milloy MJ., Cannabis Cannabinoid Res. 2023
Navigating Evidence, Challenges, and Caution in the Treatment of Stimulant Use Disorders
Bahji A, Danilewitz M, Crockford D., Brain Sci. 2023
Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited
Bahji A, Danilewitz M, George TP, Dhaliwal A, Crockford DN., CMAJ. 2023
The development and evaluation of a provider-focused educational intervention about alcohol use disorder in patients with cirrhosis
Johnson E, Ghosh M, Daniels VJ, Wild TC, Campbell-Scherer D, Mellinger J, Winder GS, Fernandez AC, Kirkwood J, Tandon P. Can Liver J. 2023
Flawed reports can harm: the case of supervised consumption services in Alberta
Salvalaggio G, Brooks H, Caine V, Gagnon M, Godley J, Houston S, Kennedy MC, Kosteniuk B, Livingston J, Saah R, Speed K, Urbanoski K, Werb D, Hyshka E., Can J Public Health. 2023
Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis
Bahji A, Lunsky I, Gutierrez G, Vazquez G. , J Psychoactive Drugs. 2025
Canadian newspaper coverage on harm reduction featuring bereaved mothers: A mixed methods analysis
Morris H, Wild TC, Giovannoni M, Haines-Saah R, Koziel J, Schulz P, Bwala H, Kunyk D, Bubela T, Hyshka E., PLoS One. 2023
Associations between Gender Expression, Protective Coping Strategies, Alcohol Saliency, and High-Risk Alcohol Use in Post-Secondary Students at Two Canadian Universities
Bahji A, Boonmak P, Koller M, Milani C, Sutherland C, Horgan S, Chen SP, Patten S, Stuart H., Int J Environ Res Public Health., 2024
Initiation à faible dose de buprénorphine/naloxone pour la gestion de la douleur chronique non cancéreuse chez les patients sous traitement à long terme aux opioïdes : une série de cas
Rattanavong M, Kwan D, Jorgenson D, Landry E, Marwah R, Halpape K., Can J Pain., 2024
Facteurs associés à l’initiation fréquente de la buprénorphine / naloxone dans une enquête nationale auprès des médecins d’urgence canadiens
MacKinnon N, Lane D, Scheuermeyer F, Kaczorowski J, Dong K, Orkin AM, Daoust R, Moe J, Andolfatto G, Klaiman M, Yan J, Koh JJ, Crowder K, Atkinson P, Savage D, Stempien J, Besserer F, Wale J, Kestler A.,
Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study
Dubois C, Lunghi C, Eurich DT, Dyck JRB, Hyshka E, Hanlon JG, Zongo A., Schizophr Res., 2024
Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review
Bahji A., J Clin Med., 2024
Perspectives of patients who inject drugs on a needle and syringe program at a large acute care hospital
Brooks HL, Speed KA, Dong K, Salvalaggio G, Pauly BB, Taylor M, Hyshka E. , PLoS One., 2024
Un programme de sensibilisation initié par le service d’urgence pour les patients atteints de trouble lié à l’usage d’opioïdes est associé à une augmentation de la thérapie des agonistes et à l’engagement dans les soins aux dépendances : une étude de cohorte d’un an
Lakkadghatwala R, Lane D, Scheuermeyer F, Hilburt J, Buxton J, Johnson C, Nolan S, Sutherland C, Moe J, Daoust R, Dong K, Christenson J, Miles I, Orkin A, Whyte M, Kestler A., Sous-traitance de la politique précédente, 2024
Expériences négatives durant l’enfance et consommation problématique de cannabis : le rôle de la dysrégulation émotionnelle et de l’impulsivité affective
Vieira JL, Snaychuk LA, Milicevic J, Hodgins DC, Shead NW, Keough MT, Kim HS., Cannabis, 2024
Accès et utilisation de la naloxone à domicile chez les personnes âgées vivant avec la douleur : une revue d’analyse
Chan RRD, Yakiwchuk EM, Halpape K., Can J Hosp Pharm., 2024
Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada
Dubois C, Fernandes H, Lin M, Martins KJB, Dyck JRB, Klarenbach SW, Richer L, Jess E, Hanlon JG, Hyshka E, Eurich DT., BMC Public Health., 2024
Le besoin d’une réponse de santé publique élargie et fondée sur des données probantes face à la crise des surdoses et à l’approvisionnement en drogues toxiques au Canada
Hyshka, E., Moore, D.M., Knight, R. et al., Can J Public Health, 2024
Obstacles et facilitateurs pour les médecins de famille prescrivant une thérapie par agonistes opioïdes en Saskatchewan
Nguyen T, Bareham J, Halpape K., médecin de famille canadien, 2024
A Cross-sectional Study of Opioid Agonist Therapy Barriers and Facilitators
Duff, E., Fehr, C., Shams, S., Wintoniw, S., Devenney, A., Ashfield, D., & O’Rourke, T., The Journal for Nurse Practitioners, 2024
Quitter les services d’urgence sans compléter les traitements chez les patients des Premières Nations et non autochtones en Alberta : une étude à méthodes mixtes
McLane P, Bill L, Healy B, Barnabe C, Plume TB, Bird A, Colquhoun A, Holroyd BR, Janvier K, Louis E, Rittenbach K, Curtin KD, Fitzpatrick KM, Mackey L, MacLean D, Rosychuk RJ., CMAJ, 2024
Cannabis legalization and hospitalizations in Alberta: Interrupted time series analysis by age and sex
Kim C, Bai Y, Allin S, Kirst M, O’Campo P, Ienciu K, Xia X, MacMaster F, Rittenbach K, Chum A., J Addict Dis., 2024
Capacity, Rationality, and the Promotion of Autonomy: A Trauma-Informed Approach to Refusals of Care After Opioid Poisoning
Cattell C, Hyshka E, Leier B, Mack C., Am J Bioeth., 2024
Le rôle du lien humain-chien dans le rétablissement du trouble lié à l’usage de substances : une revue de portée et une synthèse narrative
Dell, C., Kosteniuk, B., Doi, C., Chalmers, D., & Butt, P., Interactions humain-animal, 2024
Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review
Englander H, Thakrar AP, Bagley SM, Rolley T, Dong K, Hyshka E. , JAMA Intern Med., 2024
Disparities in cannabis-related emergency department visits across depressed and non-depressed individuals and the impact of recreational cannabis policy in Ontario, Canada
Kim C, Dusing GJ, Nielsen A, MacMaster FP, Rittenbach K, Allin S, O’Campo P, Penney TL, Hamilton HA, Kirst M, Chum A., Psychol Med., 2023
Evaluation of an infographic: prescription drug misuse among older adults in Saskatchewan
Alphonsus, K., Ahmed, M. D., Scheck, H., & Fornssler, B., Journal of Substance Use, 2024
Engaging families and parent advocates in research on substance use and drug policy reform: Guiding principles from a Canadian community-academic partnership
Haines-Saah RJ, Morris H, Schulz P, Jenkins E, Hyshka E. , Drug Alcohol Rev, 2024
Évaluation du soutien aux politiques sur l’usage de substances auprès du grand public et des influenceurs politiques dans deux provinces canadiennes
Curtin KD, Thomson M, Hyshka E, Colman I, Wild TC, Belon AP, Nykiforuk CIJ., Sous-traitance des abus Politiques précédentes, 2024
The decriminalization of illicit drugs in British Columbia: a national evaluation protocol
Russell C, Ali F, Imtiaz S, Butler A, Greer A, Rehm J., BMC Public Health., 2024
Ce que les psychiatres devraient savoir à propos d’un approvisionnement en opioïdes plus sécuritaire sur ordonnance
Bahji A, Danilewitz M, Sachdev A, Mathew N, Lamba W, Rafizadeh R, Chopra N, Dhaliwal A, George TP, Crockford D, Primeau V, Tibbo P, Buckley L, Tanguay R., Can J Psychiatry., 2024
Safer supply and political interference in medical practice: Alberta’s Narcotics Transition Services
Wilson P, Colizza K, Hyshka E., Int J Drug Policy., 2024
Examen de l’association entre les dépenses des unités de santé publique et la consommation de substances chez les adolescents
Rai U, Patte KA, Smith BT, Senthilselvan A, Hyshka E, Leatherdale ST, Pabayo R., Heliyon, 2024
Prédicteurs de l’évolution de l’état d’utilisation du cannabis de la légalisation pré- à la post-récréative du cannabis au Canada : preuves d’une enquête nationale longitudinale en deux vagues
McGrath DS, Williams RJ, Allami Y, Christensen DR, Hodgins DC, Nicoll F, Shaw CA, Stevens RMG., Cannabis, 2024
Substance use as a public health issue: A critical review of the Canadian literature, 1896-2020
Crépault JF, Emerson B, Hyshka E, Strike C, Room R, Rehm J., Int J Drug Policy., 2024
Santé mentale et prédicteurs dispositionnels de la consommation simultanée versus concurrente de cannabis et d’alcool dans un contexte canadien
Vieira JL, Coelho SG, Snaychuk LA, Tabri N, Dawson SJ, Hodgins DC, Keough MT, Shead NW, Kim HS., Cannabis, 2024
Therapy dogs contribute to a more ‘caring’ emergency department environment for patients with mental health and substance use challenges
Dell CA, Pavelich AR, Stempien J., CJEM, 2024
Expériences des professionnels de la santé travaillant dans des programmes de traitement agoniste aux opioïdes injectables : Une analyse thématique qualitative
Gadimova, F; Jackson, J., Journal of Addictions Nursing
Comment faire progresser la question des débris d'aiguilles? Une étude qualitative par entretiens avec analyse thématique réflexive, tirée de SANDS (Strategies for Addressing Needle Debris Study)
Jackson, J; Ainsley, E; Perry, S; Gadimova, F; Ens, T; Cameron, T; Francisco, R; Hon, A; Kim, Y; McGill, E; Patel, T; Sodhi, S; Yu, J; Ginn, C., The Canadian Journal of Addiction
Mise en œuvre de services de réduction des méfaits pour les personnes qui consomment des drogues fournis par le personnel des pharmacies : un protocole d'examen de la portée
Navarrete J, Hughes C, Kung JY, Salokangas E, Taylor M, Hyshka E., BMJ Open
Différences dans les taux de surdose selon le genre dans les services de consommation supervisée : une étude séquentielle explicative à méthodes mixtes
Muel, E., Fan, E., Ginn, C., & Jackson, J., Drugs: Education, Prevention and Policy
Élargir les services de consommation supervisée dans les régions rurales du Canada : Combler les lacunes
Mirza, N., Mathias, H., Hyshka, E., Can J Public Health
Rôle des pharmaciens en médecine des dépendances dans les systèmes de santé publics du Canada : Une étude qualitative
Weibe, A., Pecson, R., Coupland, M., Halpape, K., Can J Hospital Pharm.
Recherche participative communautaire en milieu rural avec les familles de personnes qui consomment des drogues : considérations clés issues d'un partenariat de recherche multiprovincial.
Mathias, H., Duff, E., Schulz, P. et al., Harm Reduct J.
Répondre aux méfaits liés à la drogue au sein des populations sud-asiatiques au Canada
Mirza, N., Singh, M. & Hyshka, E., Can J Public Health
Perspectives des médecins sur la réduction des méfaits et le soutien aux patients des urgences qui consomment des drogues
Zoe K. D. Collins, Elaine Hyshka, Karine J. Lavergne, Savannah M. Weber, Ginetta Salvalaggio, Cindy Jiaxin Xue, Arlanna Pugh, Janusz Kaczorowski, Aaron M. Orkin, Andrew Kestler, Kathryn A. Dong, PLoS One
